Search Results

You are looking at 1 - 3 of 3 items for

  • Author: Claes-Göran Östenson x
  • Refine by access: Content accessible to me x
Clear All Modify Search
Annika M Svensson
Search for other papers by Annika M Svensson in
Google Scholar
PubMed
Close
,
Claes-Göran Östenson
Search for other papers by Claes-Göran Östenson in
Google Scholar
PubMed
Close
,
Birgitta Bodin
Search for other papers by Birgitta Bodin in
Google Scholar
PubMed
Close
, and
Leif Jansson
Search for other papers by Leif Jansson in
Google Scholar
PubMed
Close

The effects of a 60% partial pancreatectomy were studied in hyperglycemic GK (Goto–Kakizaki) rats. Partial pancreatectomy or a sham operation was performed on 12-week-old female Wistar rats, GK rats or hybrids between male GK rats and female Wistar rats. Measurements of pancreatic blood flow and islet blood flow were performed by a microsphere technique 2 weeks after surgery. Glucose tolerance was decreased in hybrid compared with Wistar rats, and in GK rats compared with both hybrid and Wistar rats before surgery. Partial pancreatectomy induced minor changes in glucose tolerance. Wistar rats had a decreased islet mass following partial pancreatectomy. Both hybrid and GK rats showed a significant decrease in relative islet volume, but only GK rats in total islet mass, compared with Wistar rats 2 weeks after surgery. Pancreatic blood flow and islet blood flow did not significantly differ between sham-operated Wistar, hybrid or GK rats. After partial pancreatectomy, islet blood flow in relation to islet mass increased 3-fold in Wistar rats and 2-fold in hybrid rats. In contrast, GK rats showed no increase in islet blood flow following partial pancreatectomy. It is concluded that compensatory mechanisms after partial pancreatectomy are operating less effciently in hybrid and GK rats.

Free access
Kylie S Foo Departments of, Neuroscience, Microbiology, Molecular Medicine and Surgery

Search for other papers by Kylie S Foo in
Google Scholar
PubMed
Close
,
Hanna Brauner Departments of, Neuroscience, Microbiology, Molecular Medicine and Surgery

Search for other papers by Hanna Brauner in
Google Scholar
PubMed
Close
,
Claes-Göran Östenson Departments of, Neuroscience, Microbiology, Molecular Medicine and Surgery

Search for other papers by Claes-Göran Östenson in
Google Scholar
PubMed
Close
, and
Christian Broberger Departments of, Neuroscience, Microbiology, Molecular Medicine and Surgery

Search for other papers by Christian Broberger in
Google Scholar
PubMed
Close

The protein nucleobindin-2 (NUCB2, also known as nesfatin) was recently implicated as a mediator of anorexia and catabolism in the central nervous system, and has been suggested to act as a cleaved and secreted messenger. Given the overlap of signalling molecules between the brain and pancreas, we have explored the presence of NUCB2 in the islets of Langerhans. We also performed an investigation of the dynamic regulation of pancreatic NUCB2 in different metabolic states. NUCB2-like immunoreactivity was detected by immunofluorescence in all human and rat islet β-cells (as detected by co-localization with insulin), but not in other islet cells or in the exocrine pancreas. Islet NUCB2 content, as measured by enzyme immunoassay, did not change significantly following an overnight fast, but was substantially lower in islets isolated from an animal model of type 2 diabetes, the Goto-Kakizaki (GK) rats (48% of non-diabetic Wistar rat control). Serum levels, however, were not different between Wistar and GK rats. The release of NUCB2 from isolated rat islets was significantly elevated following glucose challenge (123%), but this effect was substantially lower than that observed for insulin (816%). In contrast, serum levels of NUCB2 showed a reversible decrease in an i.p. glucose tolerance test. These data suggest a role for NUCB2 in β-cell function and a potential involvement in diabetic pathology. However, our findings, together with previous reports, appear more compatible with intracellular actions rather than with endocrine/paracrine communication, and suggest that NUCB2 in serum derives primarily from non-islet sources.

Free access
Nguyen Khanh Hoa Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Department of Pharmacology, Hanoi Medical University, Hanoi, Vietnam
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Institute of Material Medica, Hanoi, Vietnam
Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Nguyen Khanh Hoa in
Google Scholar
PubMed
Close
,
Åke Norberg Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Department of Pharmacology, Hanoi Medical University, Hanoi, Vietnam
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Institute of Material Medica, Hanoi, Vietnam
Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Åke Norberg in
Google Scholar
PubMed
Close
,
Rannar Sillard Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Department of Pharmacology, Hanoi Medical University, Hanoi, Vietnam
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Institute of Material Medica, Hanoi, Vietnam
Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Rannar Sillard in
Google Scholar
PubMed
Close
,
Dao Van Phan Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Department of Pharmacology, Hanoi Medical University, Hanoi, Vietnam
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Institute of Material Medica, Hanoi, Vietnam
Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Dao Van Phan in
Google Scholar
PubMed
Close
,
Nguyen Duy Thuan Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Department of Pharmacology, Hanoi Medical University, Hanoi, Vietnam
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Institute of Material Medica, Hanoi, Vietnam
Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Nguyen Duy Thuan in
Google Scholar
PubMed
Close
,
Dang Thi Ngoc Dzung Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Department of Pharmacology, Hanoi Medical University, Hanoi, Vietnam
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Institute of Material Medica, Hanoi, Vietnam
Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Dang Thi Ngoc Dzung in
Google Scholar
PubMed
Close
,
Hans Jörnvall Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Department of Pharmacology, Hanoi Medical University, Hanoi, Vietnam
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Institute of Material Medica, Hanoi, Vietnam
Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Hans Jörnvall in
Google Scholar
PubMed
Close
, and
Claes-Göran Östenson Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Department of Pharmacology, Hanoi Medical University, Hanoi, Vietnam
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
Institute of Material Medica, Hanoi, Vietnam
Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Claes-Göran Östenson in
Google Scholar
PubMed
Close

We recently showed that phanoside, a gypenoside isolated from the plant Gynostemma pentaphyllum, stimulates insulin secretion from rat pancreatic islets. To study the mechanisms by which phanoside stimulates insulin secretion. Isolated pancreatic islets of normal Wistar (W) rats and spontaneously diabetic Goto-Kakizaki (GK) rats were batch incubated or perifused. At both 3.3 and 16.7 mM glucose, phanoside stimulated insulin secretion several fold in both W and diabetic GK rat islets. In perifusion of W islets, phanoside (75 and 150 μM) dose dependently increased insulin secretion that returned to basal levels when phanoside was omitted. When W rat islets were incubated at 3.3 mM glucose with 150 μM phanoside and 0.25 mM diazoxide to keep K-ATP channels open, insulin secretion was similar to that in islets incubated in 150 μM phanoside alone. At 16.7 mM glucose, phanoside-stimulated insulin secretion was reduced in the presence of 0.25 mM diazoxide (P<0.01). In W islets depolarized by 50 mM KCl and with diazoxide, phanoside stimulated insulin release twofold at 3.3 mM glucose but did not further increase the release at 16.7 mM glucose. When using nimodipine to block L-type Ca2+ channels in B-cells, phanoside-induced insulin secretion was unaffected at 3.3 mM glucose but decreased at 16.7 mM glucose (P<0.01). Pretreatment of islets with pertussis toxin to inhibit exocytotic Ge-protein did not affect insulin response to 150 μM phanoside. Phanoside stimulated insulin secretion from Wand GK rat islets. This effect seems to be exerted distal to K-ATP channels and L-type Ca2+ channels, which is on the exocytotic machinery of the B-cells.

Free access